Astrazeneca UK Ltd v Albemarle International Corp & Anor
Clause H of the supply agreement imposed a binding obligation on AstraZeneca to disclose to Albemarle the details of any third party offer for propofol and afford Albemarle the opportunity to match that offer. AstraZeneca breached clause H by awarding the contract to Sochinaz without giving Albemarle that opportunity and by refusing to award the business to Albemarle when it matched the offer. Albemarle was entitled to terminate the supply agreement for this breach. Albemarle's breach of delivery obligations did not excuse AstraZeneca's breach of clause H. Clause D8 did not oblige Albemarle to sell safety stock to AstraZeneca. Clause M limited AstraZeneca's damages for non-delivery but...
- Parties
- Claimant: AstraZeneca UK Limited; First Defendant: Albemarle International Corporation; Second Defendant: Albemarle Corporation
- Jurisdiction
- England and Wales
- Judgment Date
- 21 June 2011
- Procedural Posture
- Commercial Contract Dispute / Judgment After Trial of Liability and Construction Issues
- Outcome
- Judgment for Albemarle on liability for breach of clause H; judgment for AstraZeneca for limited damages for Albemarle's breach of delivery obligations; quantum of Albemarle's damages to be determined at a later trial.
- Legal Topics
- Right of First Refusal, Breach of Contract, Damages, Limitation of Liability, Supply Agreements
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
AstraZeneca UK Limited
Claimant
Albemarle International Corporation
First Defendant
Albemarle Corporation
Second Defendant
Procedural Posture
Commercial Contract Dispute / Judgment After Trial of Liability and Construction Issues
Legal Issues
- 1 Meaning and effect of clause H (right of first refusal) in the supply agreement
- 2 Whether AstraZeneca breached clause H by not giving Albemarle the opportunity to match a third party offer
- 3 Whether Albemarle matched the third party offer
Ratio Decidendi
Clause H of the supply agreement imposed a binding obligation on AstraZeneca to disclose to Albemarle the details of any third party offer for propofol and afford Albemarle the opportunity to match that offer. AstraZeneca breached clause H by awarding the contract to Sochinaz without giving Albemarle that opportunity and by refusing to award the business to Albemarle when it matched the offer. Albemarle was entitled to terminate the supply agreement for this breach. Albemarle's breach of delivery obligations did not excuse AstraZeneca's breach of clause H. Clause D8 did not oblige Albemarle to sell safety stock to AstraZeneca. Clause M limited AstraZeneca's damages for non-delivery but...
Court Disposition
Judgment for Albemarle on liability for breach of clause H; judgment for AstraZeneca for limited damages for Albemarle's breach of delivery obligations; quantum of Albemarle's damages to be determined at a later trial.
Orders
- AstraZeneca's damages for Albemarle's breach of delivery obligations limited to the purchase price of undelivered DIP under clause M.
- Albemarle entitled in principle to damages for AstraZeneca's breach of clause H, not excluded or limited by clause M; quantum to be determined at a subsequent trial.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment